Ligand Guided Selection (LIGS) of Artificial Nucleic Acid Ligands against Cell Surface Targets
- 2 December 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 3 (5) , 2545-2552
Abstract
With the success of RNA-based therapeutic drugs, the demand has increased for sophisticated nucleic-acid-based targeting agents. Nucleic acid aptamers (NAAs), in this regard, represent a suitable class of molecules with synthetic versatility. Aptamers are composed of single-stranded RNA/DNA/XNA molecules, which can be identified using a method called systematic evolution of ligands by exponential enrichment (SELEX) against any molecule. This Spotlight summarizes the recent introduction of ligand guided selection (LIGS), which will permit the identification of a wide range of functional aptamers against complex targets such as cell surface receptors while maintaining their native functional state. Aptamers identified from LIGS will allow researchers to develop aptamers in biomedicine as low-cost, stable therapeutic agents and diagnostic molecules or biochemical devices.Keywords
Funding Information
- National Institute of General Medical Sciences (GM122648)
This publication has 40 references indexed in Scilit:
- The role of G-quadruplex structures of LIGS-generated aptamers R1.2 and R1.3 in IgM specific recognitionInternational Journal of Biological Macromolecules, 2019
- Engineered Aptamers to Probe Molecular Interactions on the Cell SurfaceBiomedicines, 2017
- Structural optimization of an aptamer generated from Ligand-Guided Selection (LIGS) resulted in high affinity variant toward mIgM expressed on Burkitt's lymphoma cell linesBiochimica et Biophysica Acta (BBA) - General Subjects, 2017
- G-quadruplex-based aptamers against protein targets in therapy and diagnosticsBiochimica et Biophysica Acta (BBA) - General Subjects, 2017
- Targeting Insulin Receptor with a Novel Internalizing AptamerMolecular Therapy Nucleic Acids, 2016
- Natural-like Replication of an Unnatural Base Pair for the Expansion of the Genetic Alphabet and Biotechnology ApplicationsJournal of the American Chemical Society, 2013
- Aptamers Evolved from Cultured Cancer Cells Reveal Molecular Differences of Cancer Cells in Patient SamplesClinical Chemistry, 2007
- A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichmentProceedings of the National Academy of Sciences, 2003
- Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified ProteinJournal of Biological Chemistry, 2001
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990